Pillstats
Rx only · Tablet · Oral

Doxazosin Mesylate

Brands: Doxazosin · Doxazosin Mesylate

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US37 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers11 labelers
Packages68
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 29 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.026$0.051$0.077$0.103Dec 2025Apr 2026Jul 2026
$0.087
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
9
Active US suppliers
44%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5.1K10K15K21K2025 Q12025 Q22025 Q32025 Q42026 Q1
17K
Rx · 2026 Q1
936K
Units dispensed
+21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager15SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown12SUPPLYING
A-S Medication Solutionsunknown9SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown5SUPPLYING
Chartwell RX, LLCunknown4SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown4SUPPLYING
Unichem Laboratories Limited, Indiaunknown3SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown4EXITED 2027
Northwind Health Company, LLCunknown2EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 21, 2026
    RECALLRecall (Class III): Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 T…

    Tablets/Capsules Imprinted with Wrong ID — Recalling firm: Unichem Pharmaceuticals USA Inc. — Nationwide